Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dacomitinib in progressive brain metastases
NCT02047747Phase 2Terminated
- Start
- Feb 2014
- Primary completion
- Feb 2016
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dacomitinib in brain metastases. Started Feb 2014; status: terminated.
02
Drugs
dacomitinib
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT02047747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047747.